ROSEN, A TOP RANKED LAW FIRM, Encourages Athira Pharma, Inc. Investors to Secure Counsel Before Important August 24 Deadline in Securities Class Action – ATHA
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of
SO WHAT: If you purchased Athira securities pursuant and/or traceable to the Company's IPO and/or during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Athira class action, go to http://www.rosenlegal.com/cases-register-2111.html or call
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a
DETAILS OF THE CASE: According to the lawsuits, the Offering documents contained and defendants made false and/or misleading statements and/or failed to disclose that: (1) the research conducted by the Company's Chief Executive Officer and President,
To join the Athira class action, go to http://www.rosenlegal.com/cases-register-2111.html or call
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
-------------------------------
Contact Information:
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/rosen-a-top-ranked-law-firm-encourages-athira-pharma-inc-investors-to-secure-counsel-before-important-august-24-deadline-in-securities-class-action--atha-301355285.html
SOURCE


Bicyclist has arm amputated after hit-and-run; authorities seek help finding driver
Helena man charged with arson in connection with house fire
Advisor News
- CT governor’s candidates claims: What’s true, and what’s misleading
- Retaining clients by giving them a memorable experience
- Addressing the longevity paradox
- Employers shift focus from retirement access to financial outcomes
- Helping widowed clients navigate their new financial reality
More Advisor NewsAnnuity News
- National Life Group expands annuity portfolio
- AM Best to Join Life/Annuity Insurance-Focused Panel Discussion at Capitol Forum Event
- USAA Earns No. 1 Ranking in JD Power Individual Annuity Study for the Third Consecutive Year
- How flexible annuities fit today’s retirement portfolios
- Foresters Financial appoints Tom Ross as chief distribution officer for U.S. annuity sales
More Annuity NewsHealth/Employee Benefits News
- The percentage of people without health insurance is growing
- MORE THAN 4 MILLION MEDICARE BENEFICIARIES WILL HAVE THEIR MEDICARE ADVANTAGE OR STAND-ALONE PRESCRIPTION DRUG PLAN TERMINATED AT THE END OF 2026
- Plans with cheaper premiums are risky business for Americans seeking lower healthcare costs
- Plans with cheaper premiums are risky business for Americans seeking lower healthcare costs
- ATTORNEY GENERAL BRENNA BIRD HOLDS LAST MEDICAID FRAUD ELIMINATION TASK FORCE MEETING, MAKES RECOMMENDATIONS TO GOVERNOR
More Health/Employee Benefits NewsLife Insurance News